Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Infect Control Hosp Epidemiol ; 45(1): 63-67, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37448222

ABSTRACT

OBJECTIVE: To investigate parechovirus-A3 (PeV-A3) transmission in a newborn nursery, after encountering 3 neonates with fever and rash. DESIGN: An observational study. SETTING: At a newborn nursery at the general hospital in Hyogo, Japan. PARTICIPANTS: Symptomatic neonates and their family members, and asymptomatic neonates born during the same period. METHODS: PCR assays for PeV-A and genotyping were used for the investigation of PeV-A3. Preserved umbilical cords were used to identify the route of transmission. RESULTS: PeV-A3 infection was confirmed in the three symptomatic neonates. The index case had fever and rash, and the 2 neonates treated later became symptomatic and had serum, cerebrospinal fluid, and stool specimens that were positive for PeV-A3 on PCR. The umbilical cord of the index case was positive for PeV-A3 on PCR. The family members of the index case, including the mother, were asymptomatic before delivery. The older sister and cousin of the PeV-A3-infected neonate had positive PCR results. The sequence analysis suggested 2 possible transmission routes: vertical and horizontal transmission in a newborn nursery and/or a family outside the hospital. The incubation period of PeV-A3 infection was estimated to be 1-3 days (maximum, 7 days). CONCLUSION: Horizontal transmission of PeV-A3 was confirmed in a newborn nursery. Vertical transmission was suggested by the detection of RNA in an umbilical cord sample from the index case. These observations indicate that PeV-A3 can be horizontally transmitted in a newborn nursery and that special caution is required to prevent healthcare-associated transmission of PeV-A3.


Subject(s)
Exanthema , Parechovirus , Picornaviridae Infections , Infant, Newborn , Humans , Parechovirus/genetics , Picornaviridae Infections/diagnosis , Picornaviridae Infections/epidemiology , Disease Outbreaks , Family , Fever/epidemiology
2.
Heart Vessels ; 35(10): 1463-1472, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32449049

ABSTRACT

INTRODUCTION: The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been reported to be a predictor for intravenous immunoglobulin (IVIG) resistance in patients with Kawasaki disease (KD) recently. The objective of the present study was to elucidate the predictive validity of this new marker in a multicenter study. MATERIALS AND METHODS: We retrospectively reviewed the clinical records of 520 consecutive KD patients (development data set) and 332 subsequent patients (validation data set) at 7 hospitals in Japan. RESULTS: Both NLR and PLR were significantly higher in the IVIG-resistant group than in the IVIG-responsive group. When we set the cut-off point as NLR ≥ 4.11 and PLR ≥ 119, multiple logistic regression analyses showed that a high NLR and PLR before initial IVIG were independent predictors of IVIG resistance, and their combination was a stronger predictor than either alone. The sensitivity and specificity of the combination of NLR ≥ 4.11 and PLR ≥ 119 were 0.58 and 0.73 in the development data set. Validated using an independent data set, they were 0.54 and 0.72 in the validation data set. On comparing the AUC of this predictor with those of the Gunma and Kurume scores, the AUC was highest for this predictor, followed by the Gunma score and Kurume score (0.70, 0.68, and 0.64, respectively). DISCUSSION: The predictive validity of the combination of a high NLR and PLR, which is a simple and convenient indicator, was equal to or better than that of the existing scoring systems. The new predictive marker may be a suitable indicator for predicting IVIG resistance in KD patients.


Subject(s)
Blood Platelets , Drug Resistance , Immunoglobulins, Intravenous/administration & dosage , Immunologic Factors/administration & dosage , Lymphocytes , Mucocutaneous Lymph Node Syndrome/drug therapy , Neutrophils , Child , Child, Preschool , Female , Humans , Immunoglobulins, Intravenous/adverse effects , Immunologic Factors/adverse effects , Infant , Japan , Lymphocyte Count , Male , Mucocutaneous Lymph Node Syndrome/blood , Mucocutaneous Lymph Node Syndrome/diagnosis , Platelet Count , Predictive Value of Tests , Retrospective Studies , Treatment Outcome
3.
Pediatr Int ; 59(1): 48-52, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27507671

ABSTRACT

BACKGROUND: While the association between scoliosis and cardiac and respiratory function impairments has been well characterized in clinical practice and research, the potential effect of scoliosis on urinary tract structure and renal function has received little attention. Therefore, the purpose of this study was to evaluate the preoperative clinical characteristics of urinary tract structure and renal function in pediatric patients with idiopathic scoliosis, using a combination of blood tests, urinalysis, and imaging. METHODS: Preoperative measures of urinary tract structure and renal function were obtained for 16 patients, 13-17 years old, scheduled for corrective surgery for idiopathic scoliosis. Preoperative assessment included blood test and urinalysis, combined with structural imaging on ultrasound (US), magnetic resonance imaging (MRI), magnetic resonance urography (MRU), and radioisotope tracing (RI), using technetium-99 m mercaptoacetyltriglycine (99m Tc-MAG3). Differences in blood and urine tests between patients with and without urinary tract obstruction (UTO) were evaluated for significance using Mann-Whitney U test. RESULTS: For all 16 patients, blood tests and MRU were within normal limits. Dilatation of the renal pelvis was identified on US in eight patients (50.0%). UTO was identified on RI in six patients (37.5%). UTO was associated with elevated ß2-microglobulin concentration. Urinary ß2-microglobulin concentration >0.7 µg/mg Cr differentiated patients with UTO from those without UTO, with a sensitivity of 100% and specificity of 70%. CONCLUSIONS: ß2-Microglobulin concentration may be a useful marker to screen for asymptomatic UTO in patients with idiopathic scoliosis.


Subject(s)
Scoliosis/complications , Ureteral Obstruction/etiology , Urinary Tract/pathology , Adolescent , Biomarkers/urine , Child , Female , Humans , Kidney Function Tests , Magnetic Resonance Imaging , Male , Preoperative Period , Prospective Studies , Scoliosis/surgery , Technetium Tc 99m Mertiatide/administration & dosage , Ureteral Obstruction/diagnostic imaging , Ureteral Obstruction/surgery , Ureteral Obstruction/urine , Urography , beta 2-Microglobulin/urine
4.
Pediatr Int ; 51(5): 617-20, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19438829

ABSTRACT

BACKGROUND: Measles infection can be fatal in pediatric patients with chronic renal failure or in patients who have undergone renal transplantation, both of whom are in the immunosuppressed state. The efficacy of single, live measles vaccination in preventing infection was examined. METHODS: Of 156 children with renal failure who underwent renal transplantation, the changes in antibody titer were investigated before and after renal transplantation in 125 children whose measles antibody titer could be examined, together with disease and vaccination histories. Live measles vaccine was administered to 42 children with negative antibody titer. The antibody seroconversion rate was then investigated in these children, along with rate of antibody maintenance and degree of antibody titer elevation. RESULTS: Seroconversion rate was 97.6%. Antibody titers measured on HI and EIA were 72 +/- 118 fold (HI) and 36.9 +/- 31.3 (EIA), respectively. The geometric mean of the increase in antibody titer 6 months after vaccination was 15. No side-effects of vaccination were observed in any of the children. CONCLUSIONS: Live measles vaccination of children with chronic renal failure is effective and safe, because the seroconversion rate, rate of antibody titer maintenance and degree of antibody titer elevation in children with chronic renal failure were all equivalent to those of healthy children.


Subject(s)
Antibodies, Viral/blood , Kidney Failure, Chronic/immunology , Measles Vaccine/immunology , Measles virus/immunology , Measles/immunology , Measles/prevention & control , Child , Female , Humans , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/surgery , Kidney Transplantation , Male , Measles/blood , Measles Vaccine/blood , Vaccination
5.
Pediatr Nephrol ; 19(11): 1232-6, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15322892

ABSTRACT

Steroid-resistant nephrotic syndrome (SRNS) in children is intractable, and the optimal treatment regimen is not known. We investigated the efficacy of methylprednisolone pulse therapy (MPT) in SRNS patients. Using only MPT plus heparin, we have treated ten pediatric SRNS patients that were resistant to cyclophosphamide (CPM) or cyclosporin A (CsA) and predicted to have a very poor prognosis. Administration of 30 mg/kg per day methylprednisolone with heparin for 3 days was taken as one course, and this was given 14 times over 2 years. One patient discontinued MPT because of peritonitis. Of the remaining nine patients, complete remission was achieved by four patients, persistent mild proteinuria remained in three patients, and no effect was observed in two patients. All patients that had been diagnosed with minimal change (MC) pathology ( n=3) at the initial renal biopsy achieved complete remission. Observed adverse events were peritonitis in one patient and a transient decrease in pulse rate only during MPT in one patient. These results demonstrate that MPT with heparin can induce remission in children with SRNS, even when the patient is resistant to CPM and CsA.


Subject(s)
Glucocorticoids/administration & dosage , Methylprednisolone/administration & dosage , Nephrotic Syndrome/drug therapy , Adolescent , Child , Child, Preschool , Cyclophosphamide/therapeutic use , Cyclosporine/therapeutic use , Drug Resistance , Female , Glomerulosclerosis, Focal Segmental/complications , Humans , Immunosuppressive Agents/therapeutic use , Infant , Male , Nephrosis, Lipoid/complications , Nephrotic Syndrome/etiology , Pulse Therapy, Drug , Treatment Failure , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...